Text Size

Screening for Glaucoma in Namil Area, South Korea

This study has been completed.
Sponsor:
Information provided by:
Korean Glaucoma Society
ClinicalTrials.gov Identifier:
NCT00727168
First received: July 30, 2008
Last updated: August 1, 2008
Last verified: August 2008
History of Changes
  Purpose

The purpose of this study is to study the prevalence of glaucoma in Korea, the investigators selected Namil area in Geumsan city, located in central Korea. The residents aged over 40 in this area are to be recruited to full ophthalmologic examination to detect and classify the glaucoma.


Condition
Glaucoma
Intraocular Pressure
Optic Nerve Head
Visual Field

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Epidemiologic Study for the Prevalence of Glaucoma in Namil Area, Geumsan City, South Korea

Resource links provided by NLM:

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Further study details as provided by Korean Glaucoma Society:

Primary Outcome Measures:
  • Prevalence of glaucoma in Namil area [ Time Frame: cross-sectional ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Clinical factors associated with the glaucoma [ Time Frame: cross-sectional ] [ Designated as safety issue: No ]

Enrollment: 1532
Study Start Date: November 2007
Study Completion Date: February 2008
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Detailed Description:

Screening includes following examinations; Questionaire and Consent form, Visual acuity test, Auto-refraction, IOL Master measurement, Pachymetry, FDT Perimetry, Fundus Photography, Slit lamp examination, Goldmann applanation Tonometry, Gonioscopy, and Binocular optic disc evaluation. For the cases showing any abnormality in FDT perimetry, optic disc morphology, or intraocular pressure, Humphrey automated visual field test is to be performed as an extended examination. Finally, optic nerve head evaluation by OCT or GDx analyzer is to be used as a confirmation test, as well as additional Humphrey visual field test.

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

All residents aged over 40 in Namil area in Geumsan city

Criteria

Inclusion Criteria:

  • All residents aged over 40 in Namil area

Exclusion Criteria:

  • Individuals registered but not actually living in this area
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00727168

Locations
Korea, Republic of
Yongdong Severance Hospital
Seoul, Korea, Republic of, 135-720
Sponsors and Collaborators
Korean Glaucoma Society
Investigators
Principal Investigator: Gong-je Seong, MD, PhD Korean Glaucoma Society
  More Information

No publications provided by Korean Glaucoma Society

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Gong-je Seong, president, Korean Glaucoma Society
ClinicalTrials.gov Identifier: NCT00727168     History of Changes
Other Study ID Numbers: CNUH81510-9701
Study First Received: July 30, 2008
Last Updated: August 1, 2008
Health Authority: Korea: Food and Drug Administration

Keywords provided by Korean Glaucoma Society:
prevalence study
glaucoma

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on May 16, 2013